Analyst Ratings For MYOV – Myovant Sciences (NYSE:MYOV)
Today, MYOV – Myovant Sciences (NYSE:MYOV) stock was downgraded by Barclays from Overweight to Equal Weight with a price target of $18.00.
Some recent analyst ratings include
- 4/5/2018-Barclays was Downgraded by analysts at Barclays from a “Overweight ” rating to a ” Equal Weight” rating. They now have a $18.00 price target on the stock.
- 11/14/2017-Cowen Reiterated Rating of Buy.
- 11/10/2017-Robert W. Baird Reiterated Rating of Buy.
- 10/4/2017-JMP Securities Reiterated Rating of Outperform.
- 8/16/2017-Evercore ISI initiated coverage with a Outperform rating.
- 11/21/2016-Citigroup initiated coverage with a Buy rating.
Recent Insider Trading Activity For MYOV – Myovant Sciences (NYSE:MYOV)
MYOV – Myovant Sciences (NYSE:MYOV) has insider ownership of 3.00% and institutional ownership of 81.44%.
- On 4/2/2018 Holdings Ltd. Dexxon, Major Shareholder, bought 1,110,015 with an average share price of $20.27 per share and the total transaction amounting to $22,500,004.05.
- On 3/19/2018 Pharmaceuticals Interna Takeda, Major Shareholder, bought 7,420,625 with an average share price of $18.67 per share and the total transaction amounting to $138,543,068.75.
Recent Trading Activity for MYOV – Myovant Sciences (NYSE:MYOV)
Shares of MYOV – Myovant Sciences closed the previous trading session at 20.48 down -0.89 4.16% with 1025610 shares trading hands.
